case_images: PMC10876159_01
case_images: Short- and long-axis ultrasound of the left groin demonstrating an abnormally enlarged lymph node with abnormal morphology, measuring 2.57 cm x 1.95 cm x 1.34 cm with hypervascularity
case_images: cureus-0016-00000052630-i01.jpg
case_images: PMC10876159_01_cureus-0016-00000052630-i01.jpg
case_images: FIG1
case_images: An ultrasound of the left groin demonstrated an abnormally enlarged lymph node measuring 2.57 x 1.95 x 1.34 cm with hypervascularity (Figure 1).
case_images: Axial PET/CT imaging demonstrating low-level tracer uptake at the presumed left inguinal excisional biopsy site (blue arrow) and no definite sites of hypermetabolic malignancy.. PET/CT: positron emission tomography/computed tomography
case_images: cureus-0016-00000052630-i02.jpg
case_images: PMC10876159_01_cureus-0016-00000052630-i02.jpg
case_images: FIG2
case_images: Initial PET/CT imaging demonstrated low-level tracer uptake at the site of inguinal excision with SUV max of 2.1, diffuse low-level marrow hypermetabolism, and no evidence of definite hypermetabolic malignancy (Figure 2).
case_images: Axial PET/CT imaging demonstrated no evidence of new, persistent, or recurrent malignant disease. A previously FDG-avid lymph node in the left inguinal region has resolved nearly to the background (blue arrow). PET/CT: positron emission tomography/computed tomography; FDG: fluorodeoxyglucose
case_images: cureus-0016-00000052630-i03.jpg
case_images: PMC10876159_01_cureus-0016-00000052630-i03.jpg
case_images: FIG3
case_images: There was almost complete resolution of the fluorodeoxyglucose (FDG) active lymph node seen in the left inguinal region on the last PET/CT (Figure 3).